Webinar: Use digital pathology to automate, analyze and clinically validate prognostic biomarkers
Development and analytical validation of prognostic biomarkers for metastasis
February 9, 2021
9:00am (PST) | 12:00pm (EST)
Join us during our upcoming sponsored LabRoots webinar and live Q&A featuring David Entenberg and Regan Baird. Using whole slide imaging and digital analysis, Dr. Entenberg will share how he analytically validated an automated analysis of Tumor Microenvironment of Metastasis (TMEM) doorways that reduced pathologists’ time by an order of magnitude and enabled the rapid clinical validation of TMEM Score. In addition, he will share in this webinar how, using digital pathology, his group evaluated several different methods of combining TMEM and MenaCalc scores to create a multiparameter quantitative analysis with dramatically improved prognostic ability for distant metastasis in breast cancer patients. Following the webinar, both David Entenberg and Regan Baird will host a Q&A session to explore how digital image analysis can be harnessed for development and validation of prognostic biomarkers for potential use in therapeutic settings. Some of the highlights you can expect from this session include:
- Discuss the process of tumor cell dissemination from breast tumors.
- Summarize how live imaging studies are able to discover mechanisms of metastasis which can then be turned into prognostic biomarkers for metastasis.
- Outline how digital whole slide scanning and digital pathology can be used to automate as well as analytically and clinically validate prognostic biomarkers.
Source: Visiopharm
